Video
Sexual harassment remains high in ophthalmology
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Efficacy and safety findings for lenadogene nolparvovec (Lumevoq) from REFLECT Phase III trial
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
PulseSight Therapeutics SAS receives funds to support clinical trials of PST-611
Alcon announces US launch of Voyager direct selective laser trabeculoplasty device
